OTLK insider buying and SEC filings, explained
Outlook Therapeutics, Inc. · CIK 1649989
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$365K
Insiders who bought
3
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 14, 2026 | Other purchase | Lawrence A. Kenyon (CFO and Director) bought 202,020 shares in 2 share classes; the filing does not report a price. Holdings of Common Stock up 999%+ to 106,956 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Aug 14, 2026 | Other purchase | Robert Charles Jahr (CEO and Director) bought 303,030 shares in 2 share classes; the filing does not report a price. New position of 151,515 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 14, 2026 |
| Aug 12, 2026 | Other purchase | Ghiath M. Sukhtian (Director and 10% owner) bought 5,050,504 Common Stock in 2 share classes indirectly at about $0.4950 ($2.5M) in a public offering. Indirect holdings of Common Stock up 11% to 24,617,320 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Aug 14, 2026 |
| Jul 29, 2026 | Purchase (code P) | Faisal Ghiath Sukhtian (Director) bought 95,398 shares at $1.05 ($100K), reported as a purchase (code P). Holdings up 76% to 220,972 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 29, 2026 |
| Jun 2, 2026 | Purchase (code P) | Yezan Munther Haddadin (Director) bought 29,000 shares at $0.8300 ($24K), reported as a purchase (code P). Holdings up 78% to 66,167 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 28, 2026 | Other purchase | Ghiath M. Sukhtian (Director and 10% owner) bought 24,028,279 Warrants (right to buy) in 2 share classes indirectly at $0.5900 ($5.0M for the 8,539,709 shares with a reported price) in a private placement. New position of 8,571,428 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jun 1, 2026 |
| May 27, 2026 | Purchase (code P) | Faisal Ghiath Sukhtian (Director) bought 122,174 shares at $0.4100 ($50K), reported as a purchase (code P). Holdings up 999%+ to 125,574 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 26, 2026 | Purchase (code P) | Yezan Munther Haddadin (Director) bought 34,000 shares at $0.4400 ($15K), reported as a purchase (code P). Holdings up 999%+ to 37,167 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 26, 2026 | Purchase (code P) | Randy H. Thurman (Director) bought 5,000 shares at $0.4300 ($2K), reported as a purchase (code P). Holdings up 843% to 5,593 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
| May 26, 2026 | Purchase (code P) | Kurt J. Hilzinger (Director) bought 400,000 shares at $0.4400 ($176K), reported as a purchase (code P). Holdings up 999%+ to 423,655 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 27, 2026 |
4 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
3 insiders bought in 30 days
$265K in purchases since May 26, 2026 · Purchases traded May 26, 2026 to Jun 2, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Kurt J. Hilzinger (Director) | $176K | May 26, 2026 | SEC filing |
| Yezan Munther Haddadin (Director) | $15K | May 26, 2026 | SEC filing |
| Faisal Ghiath Sukhtian (Director) | $50K | May 27, 2026 | SEC filing |
| Yezan Munther Haddadin (Director) | $24K | Jun 2, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow OTLK in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.